LEASA GARRETT: Open Payments
NPI 1609552603 · FORT COLLINS, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$285 in 13 payments from 9 companies in 2025. Trend: 2023 $103 · 2024 $627 · 2025 $285
Food & beverage: $285
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 3 | $67 |
| ABBVIE INC. | 2 | $52 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $34 |
| Amgen Inc. | 2 | $31 |
| Boston Scientific Corporation | 1 | $25 |
| Novo Nordisk Inc | 1 | $23 |
| Exact Sciences Corporation | 1 | $21 |
| Kowa Pharmaceuticals America, Inc. | 1 | $16 |
| Cranial Technologies, Inc | 1 | $16 |
Products named: MOUNJARO, QULIPTA, CAPLYTA, EVENITY, ZEPBOUND, General - Pain Management, Ozempic, Cologuard Collection Kit.
Industry payments across CO — which companies pay providers there.
